Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > LifeSci Communications

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on May 17, 2022 1:05pm

128 Views

Post# 34689612

RE:RE:RE:RE:RE:RE:LifeSci Communications

It is a disappointing initial reaction but with lack of PR and tough market conditions its not that surprising. Bottom line with this validation derisking it we should rerate to 1B US. Market is inefficient and its not going to happen all at once but more institutional buying should step in. Be nice to see this followed by a TSX uplist.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario